Discover how AI healthcare technology and machine learning diagnosis are transforming disease detection, improving accuracy, and reshaping patient care in today's evolving medical landscape.

Protein Biomarkers May Play an Important Role in Overcoming Limitations of Circulating Tumor DNA for Screening Early-Stage ...

Talk about being a dedicated paw-rent. When his 8-year-old dog Rosie had mere months to live due to deadly mast cell cancerous tumors, Australian tech entrepreneur Paul Conyngham took matters into his ...

Researchers at Mass General Brigham have developed a series of artificial intelligence (AI) tools that uses machine learning ...

New research shows an AI-driven liquid biopsy analyzing genome-wide cfDNA fragment patterns can detect early liver fibrosis & cirrhosis and may signal broader chronic disease burden.

An innovative platform developed by PKU researchers called "cf-EpiTracing" has proved capable of detecting and tracing ...

A tech executive utilized artificial intelligence and genomic analysis to develop a personalized experimental cancer vaccine ...

Researchers at Mass General Brigham have developed a series of artificial intelligence (AI) tools that uses machine learning to identify individuals who may be at risk for intimate partner violence ...

Market has emerged as a rapidly expanding segment within the oncology diagnostics and liquid biopsy landscape. Circulating ...

Advanced proteomics and AI reveal blood protein changes, offering insights into early Alzheimer's detection and differentiation from mild cognitive impairment.

(Nasdaq: GRAL), a healthcare company whose mission is to detect cancer early when it can be cured, today announced that Bob Ragusa will retire as Chief Executive Officer, effective June 1, 2026. GRAIL ...